日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HMMR triggers immune evasion of hepatocellular carcinoma by inactivation of phagocyte killing

HMMR 通过灭活吞噬细胞杀伤功能引发肝细胞癌的免疫逃避

Hong Wu, Yiqiang Liu, Qianshi Liu, Zhaoshen Li, Yejian Wan, Chenhui Cao, Binghuo Wu, MingXin Liu, Renchuan Liang, Lanlin Hu, Wenyi Zhang, Mei Lan, Quan Yao, Hang Zhou, Haitao Lan, Liang Chen, Yu Zhang, Xia Zhang, Xiu-Wu Bian, Chuan Xu

Aberrant expression of MRAS and HEG1 as the biomarkers for osimertinib resistance in LUAD

MRAS 和 HEG1 的异常表达作为 LUAD 中奥希替尼耐药的生物标志物

Mingxin Liu, Bo Tang, Run Xiang, Peihong Hu, Chuan Xu, Lanlin Hu, Qiang Li

TRX2/Rab35 Interaction Impairs Exosome Secretion by Inducing Rab35 Degradation

TRX2/Rab35相互作用通过诱导Rab35降解来抑制外泌体分泌

Tao Zhang,Lili Zhao,Liping Han,Yan Li,Lanlin Hu,Huani Wang,Fangdong Zou

ITGA5 Predicts Dual-Drug Resistance to Temozolomide and Bevacizumab in Glioma

ITGA5 预测胶质瘤对替莫唑胺和贝伐单抗的双重耐药性

Ying Shi, Mengwan Wu, Yuyang Liu, Lanlin Hu, Hong Wu, Lei Xie, Zhiwei Liu, Anhua Wu, Ling Chen, Chuan Xu

PD-L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance

在获得性西妥昔单抗耐药的头颈部鳞状细胞癌模型中,PD-L1 通过 BRD2 上调

Neil E Bhola, Christian Njatcha, Lanlin Hu, Eliot D Lee, Jamie V Shiah, Mi-Ok Kim, Daniel E Johnson, Jennifer R Grandis

Repressing PDCD4 activates JNK/ABCG2 pathway to induce chemoresistance to fluorouracil in colorectal cancer cells

抑制 PDCD4 可激活 JNK/ABCG2 通路,从而诱导结直肠癌细胞对氟尿嘧啶产生化学耐药性

Lanlin Hu, Yutong Liang, Kelv Wu, Caixia Wang, Tao Zhang, Rui Peng, Fangdong Zou

Gene targets of sulforaphane in head and neck squamous cell carcinoma

萝卜硫素在头颈部鳞状细胞癌中的基因靶点

Lanlin Hu, Hua Li, Eliot D Lee, Jennifer R Grandis, Julie E Bauman, Daniel E Johnson

REG4 is an indicator for KRAS mutant lung adenocarcinoma with TTF-1 low expression

REG4是KRAS突变型肺腺癌伴TTF-1低表达的指标。

Sun, Si; Hu, Zhihuang; Huang, Shenglin; Ye, Xun; Wang, Jialei; Chang, Jianhua; Wu, Xianghua; Wang, Qifeng; Zhang, Lanlin; Hu, Xingjiang; Yu, Hui